New eye drops aim to sharpen night vision in clinical trial
NCT ID NCT04638660
First seen Oct 31, 2025 · Last updated May 22, 2026 · Updated 34 times
Summary
This study tested an eye drop called Nyxol in 144 adults who have trouble seeing in dim light, often after eye surgeries like cataract or LASIK. The goal was to see if Nyxol could improve vision in low-light conditions compared to a placebo. The trial is complete, and results will show if this drop offers a safe way to ease night vision problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIM LIGHT VISION DISTURBANCES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Site 1
Petaluma, California, 94954, United States
-
Clinical Site 10
Palisades Park, New Jersey, 07650, United States
-
Clinical Site 11
Memphis, Tennessee, 38119, United States
-
Clinical Site 13
Pittsburg, Kansas, 66762, United States
-
Clinical Site 14
Louisville, Kentucky, 41008, United States
-
Clinical Site 18
Jacksonville, Florida, 32256, United States
-
Clinical Site 19
Ogden, Utah, 84403, United States
-
Clinical Site 2
Fargo, North Dakota, 58103, United States
-
Clinical Site 20
Edgewood, Kentucky, 41017, United States
-
Clinical Site 22
High Point, North Carolina, 27262, United States
-
Clinical Site 3
Jacksonville, Florida, 32204, United States
-
Clinical Site 4
Elizabeth City, North Carolina, 27909, United States
-
Clinical Site 5
San Antonio, Texas, 78240, United States
-
Clinical Site 6
Newport Beach, California, 92663, United States
-
Clinical Site 8
Pennington, New Jersey, 08534, United States
-
Clinical Site 9
High Point, North Carolina, 27262, United States
-
Clinical Test 15
Warwick, Rhode Island, 57108, United States
Conditions
Explore the condition pages connected to this study.